Zhengye Biotechnology Holding Ltd (ZYBT) KPIs and segments
Close on Nov 17, 2026Market cap $72.03MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Zhengye Biotechnology's business
Zhengye Biotechnology's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
Swine vaccines(CN¥M) | 90.1 | 158 | 189 | 236 | |
Distribution network(CN¥M) | 61.5 | 59.9 | 49.6 | 47.8 | |
Direct sales channel(CN¥M) | 51.9 | 122 | 160 | 207 | |
Other vaccines(CN¥M) | 13.7 | 13.1 | 7.30 | 8.29 | |
Poultry vaccines(CN¥M) | 12.5 | 15.5 | 15.4 | 16.4 | |
Government tender and procurement(CN¥M) | 2.96 | 4.73 | 2.50 | 5.10 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-04-28.
See a number that looks wrong?